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Abstract 
In children, levels of play, physical activity, and fitness are key indicators of health and 
disease and closely tied to optimal growth and development. Cardiopulmonary exercise 
testing (CPET) provides clinicians with biomarkers of disease and effectiveness of 
therapy, and researchers with novel insights into fundamental biological mechanisms 
reflecting an integrated physiological response that is hidden when the child is at rest. 
Yet the growth of clinical trials utilizing CPET in pediatrics remains stunted despite the 
current emphasis on preventative medicine and the growing recognition that therapies 
used in children should be clinically tested in children. There exists a translational gap 
between basic discovery and clinical application in this essential component of child 
health. To address this gap, the NIH provided funding through the Clinical and 
Translational Science Award (CTSA) program to convene a panel of experts. This 
report summarizes our major findings and outlines next steps necessary to enhance 
child health exercise medicine translational research. We present specific plans to 
bolster data interoperability, improve child health CPET reference values, stimulate 
formal training in exercise medicine for child health care professionals, and outline 
innovative approaches through which exercise medicine can become more accessible 
and advance therapeutics across the child health spectrum.  
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I. INTRODUCTION 
Physical activity in children is not merely play, but rather an essential component 
of healthy growth and development beginning in fetal life and lasting across the lifespan. 
While the idea that “exercise is good for children” seems axiomatic, translating this 
vague notion into specific, biological mechanisms that could be used to actually 
influence health has proved to be difficult. Never before has the need for such research 
been so great. We find ourselves in the midst of a troubling epidemic of pediatric 
obesity, type 2 diabetes, and the metabolic syndrome, all, in large measure, ominous 
consequences of unprecedented levels of physical inactivity and sedentary lifestyles in 
children, coupled with overnutrition.1;2 The parallel epidemic of childhood asthma seems 
equally intractable, is disproportionately affecting lower SES children,3 and is itself 
linked to physical inactivity and obesity.4-7 At the same time, therapeutic advances have 
created an increasing number of childhood survivors of a wide range of conditions, 
including premature birth, congenital heart disease, lung disease (such as cystic 
fibrosis-CF), pediatric arthritis, hematological diseases, and cancer. In these children, 
fitness is impaired, and physical activity is beneficial 8-12 only if the “exercise dose” does 
not exacerbate underlying inflammatory, metabolic, or physiological abnormalities. 
Prescribing optimal levels of exercise, identifying new clinically useful biomarkers of 
disease and therapy success, and/or using exercise to enhance drug and device 
discovery and development must be based on a better understanding of the 
mechanisms that link exercise with health and disease in the growing child. 
Exercise testing allows dynamic evaluation of a child’s response to physical 
challenge, which helps characterize cardiovascular, respiratory and metabolic 
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responses under stress and identify abnormalities that might not otherwise be evident at 
rest. Despite this valuable tool, as shown in Figure 1, we have identified a gap in 
translating new insights into the biology of exercise into clinical research targeting child 
health. Over the past 15 years advances in technology and data acquisition, such as the 
ability to capture and store large amounts of cardiovascular, respiratory, and 
neurosensory data, have fueled research involving two separate but related areas of 
interest in child health: sleep and exercise.  In both of these fields, there has been a 
robust increase in publications focused on biological mechanisms and pathophysiology. 
But as seen in Figure 1, while increasing numbers of clinical trials using sleep studies 
accompanied the growth in mechanistic research, a parallel increase in clinical trials 
utilizing cardiopulmonary exercise testing has not been nearly as robust.  
In an effort to better understand this lack of translation and to develop a strategic 
action plan to address the gap, we created the Pediatric Exercise Network-Working 
Group (PEN-WG)—collaborative of physicians and scientists from across the US, 
Canada, and Europe. PEN-WG was supported with funds made available through a 
supplemental grant to the UC Irvine Institution for Clinical and Translational Science 
from the Clinical Translational Science Award (CTSA) parent organization, the National 
Institutes of Health, in an effort to support initiatives that emanated from the CTSA-
Consortium Child Health Oversight Committee. Over an 18-month period, PEN-WG 
participated in three face-to-face meetings and hosted approximately 20 specific-topic 
webinars and phone meetings.  
Disruptive innovation is contextually defined (e.g., for industry, medicine, 
research) but arises from the notion that certain advances (typically, technological; 
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sometimes, conceptual) profoundly change existing processes of “how things are 
done.”13 The PEN-WG recognized that such an approach would be needed to address 
the child health exercise medicine translational gap that we had earlier identified.  
The PEN-WG first highlighted a set of causes and factors that likely contributed 
to the translational gap. Not surprisingly, our deliberations led to a multifaceted and 
wide-ranging array of probable mechanisms, shown in Table 1. We then focused on 
developing a series of tasks designed to address the identified causes with the ultimate 
goal of increasing and improving clinical trials that incorporate exercise and physical 
activity outcome variables.  The group mapped out a set of strategies to enhance 
clinical research using exercise testing and physical activity assessment in children that 
could be, if implemented, transformative in nature. This Special Report summarizes the 
findings of the working group and provides recommendations for “disruptive innovation” 
that resulted from this concerted effort.  
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II. CAUSES AND FACTORS CONTRIBUTING TO THE CLINICAL TRANSLATIONAL 
GAP IN CHILD HEALTH EXERCISE RESEARCH 
II.1. Semantic Interoperability and Data Harmonization–the Key to Multisite 
Success 
We first focused on key concepts of medical informatics, namely, data 
harmonization and semantic interoperability. This particular focus on semantics may at 
first glance appear to be remote and arcane for the majority of clinicians, physiologists, 
and scientists who work in the field of pediatric exercise medicine and research. In truth, 
the working group soon realized that “data harmonization”—creating robust definitions 
of key concepts and variables that facilitate interoperability—is of critical importance in 
bridging the translational research gap in child health exercise medicine and in creating 
a baseline to which variation of concepts in use by clinicians and researchers can be 
compared. Combining data collected at multiple institutions is fraught with numerous 
challenges, most notably ensuring that data elements and measurements represent the 
same concepts across institutions.  Interoperability is defined in the context of health 
care as the ability of different information technology systems, software applications and 
networks to communicate and exchange data accurately, effectively and consistently, 
so clinicians can use the information as they care for patients.14 Closely related is 
“harmonization,” the adjustment of differences and inconsistencies among different 
measurements, methods, procedures, schedules, specifications, or systems to make 
them uniform or mutually compatible.   
An example of the rewards of interoperability and harmonization is the recent 
Global Lung Initiative, which pooled data obtained in children from various parts of the 
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world. This effort yielded robust new prediction equations for lung function across age-
groups and revealed novel insights into the maturation of lung function during 
adolescence.15  Moreover, our efforts toward harmonization echo a new era of multi-
institutional synergy. Newly developed data networks will study pediatric diseases and 
outcomes across disparate health delivery models and care settings creating an 
innovative collaborative rapid improvement paradigm called the Learning Health 
System.16 We highlight below a number of areas in which novel approaches to data 
harmonization are needed if we are to advance clinical research utilization of exercise 
testing in children. 
 
II.1.1. The VO2max Conundrum–A Plan for Semantic and Syntactic Interoperability 
in Child Health Exercise Medicine and Research. Maximal oxygen uptake (VO2max) 
[3] and its related peak VO2 were considered by our working group to be the most 
widely used and informative outcome variables currently available from 
cardiopulmonary exercise testing (CPET)(Figure 2). Both variables are derived from the 
complex integration of cellular and systemic, physical-ch mical, and biological factors 
that sustain muscular work. The VO2max and peak VO2 are single values that reflect 
heterogeneous data elements with many inter-relationships, external contextual 
dependencies, and widely varying data collection protocols. Consequently, it is not 
surprising that despite its widespread acceptance, many, sometimes conflicting, 
definitions for what constitutes “maximal” exist in the current literature as shown in 
Table 2. The PEN-WG identified other concepts and phrases in need of semantic 
harmonization in child health exercise medicine and research. Included in this list are: 
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physical fitness, habitual physical activity, fatigue, exhaustion, gas exchange kinetics, 
dynamic slopes of gas exchange and CPET variables, exercise prescription, anaerobic 
threshold, heart rate variability, and oxygen debt and deficit. 
The PEN-WG recognized that clinicians, researchers, and informaticists must be 
brought together in a timely manner to define terms and create ontologies relevant to 
child health exercise medicine and research. Such cooperation is the only way to 
ensure that 1) modern informatics approaches are employed; 2) dichotomies between 
research-based and clinically based terms and concepts are eliminated; and 3) the 
electronic medical record, when populated with CPET data, will be a useful and minable 
source for clinical research in children involving CPET. As noted, a primary barrier to 
the optimal use of clinical and research exercise testing and fitness variables is a lack of 
uniformity in the language of testing, data collection, and reporting, which impedes data 
exchange and interpretation across testing sites and over time. To overcome this 
barrier, we will need infrastructure to support syntactic interoperability—the means to 
exchange and articulate the testing data across computing platforms, operating 
systems, and networks.   
Semantically interoperable CPET data that can be transported and stored is the 
foundation of a research registry. Defining the syntax of data transport and the 
semantics that support interoperability is the role of standards development 
organizations. Currently, one of the most relevant of the standards development 
organizations is Health Level 7 (HL7). HL7 is a not-for-profit, American National 
Standards Institute-accredited standards developing organization dedicated to providing 
a comprehensive framework and related standards for the exchange, integration, 
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sharing, and retrieval of electronic health information that supports clinical practice and 
the management, delivery and evaluation of health services.  
The Clinical Interoperability Council (CIC) is an HL7 working group whose 
mission is the development of standard data definitions that can be used by computer 
scientists and engineers to develop systems that are based on the clinical and research 
domain knowledge of health and disease specialties (e.g., broad categories such as 
cardiovascular disease, or specific disease categories, such as tuberculosis or 
schizophrenia). The CIC has a development framework that allows specialty groups 
such as ours to define data elements and how the elements interact with researchers, 
clinicians, and information systems in and beyond their own work environment. The 
resulting framework of detailed data elements and how they function in research and 
clinical environments is called a Domain Analysis Model (DAM). Developing a DAM for 
child health exercise medicine and research would provide definitions to facilitate and 
enhance multicenter trials, the creation of data registries, and lifespan research.  
Developing an Exercise Medicine DAM (EMDAM) can be accomplished in concurrent or 
sequential phases as outlined in Table 3. 
II.1.2. Harmonization Issues—Data Heterogeneity. To better understand the sources 
of data heterogeneity in CPET, we obtained IRB approval and collected de-identified 
CPET data sets from 18 participating institutions along with necessary meta-data. Two 
PEN-WG members were asked to interpret the data as received, and to then record 
what additional information they required to best complete the task. We collected the 
findings into common themes and associated these findings with possible solutions that 
would enable data sets to be fully interpretable at another institution. Finally, to access 
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the impact of data acquisition on data harmonization, we reviewed breath-by-breath gas 
exchange and heart rate data generated from 1,540 cardiopulmonary exercise tests 
performed at a single laboratory. For these tests, a ramp protocol was used in which the 
work rate on a cycle ergometer increased linearly until the participant reached the limit 
of his or her tolerance.  The recurring barriers identified by investigators as they 
attempted to interpret data sets provided by other institutions are shown in Table 4. 
Despite the diversity in data sets, formats, and exercise protocols, investigators 
frequently cited the same issues as listed in the table.   
 
II.2. The Need for Norms 
There is growing recognition among researchers and clinicians that “children are 
not just miniature adults” and that, consequently, renewed resources are needed and in 
many cases have been mobilized to support the development of drugs and devices 
focused specifically on children.17;18 Clinical investigators are increasingly aware of 
regulatory incentives to perform clinical trials on drugs used specifically for childhood 
diseases, rather than relying on studies that had been done in adults. Moreover, clinical 
researchers understand that effective clinical trials focused on childhood disease must 
be accompanied by improved laboratory reference standards developed for children.  
In a recent comprehensive review, Shaw et al.19 outlined the challenges facing 
the development of laboratory reference values in pediatrics. Although focused primarily 
on blood biomarkers, the following summary particularly resonated with the PEN-WG, 
“Reliable and accurate reference intervals for laboratory analyses are integral for correct 
interpretation of clinical laboratory test results and, therefore, for appropriate clinical 
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decision-making. Ideally, reference intervals should be established based on a healthy 
population and stratified for key covariates including age, gender and ethnicity. 
However, establishing reference intervals can be challenging as it requires the 
collection of large numbers of samples from healthy individuals. This challenge is further 
augmented in pediatrics, where dynamic changes due to child growth and development 
markedly affect circulating levels of disease biomarkers.” The PEN-WG recognized that 
much work needs to be done in CPET to ensure robust and useful reference values that 
can facilitate clinical investigation. As shown in Figure 3, maximal and peak VO2 
reference values remain quite variable. 
 Shaw and colleagues additionally highlighted the need to establish “emerging 
biomarkers of cardiovascular and metabolic diseases.” They cited the fairly recent 
American Academy of Pediatrics guidelines of screening for cholesterol and triglyceride, 
and echoed the sentiment that while well-intentioned, substantial controversy surrounds 
the implementation of large-scale lipid screening in children.20 With mounting literature 
suggesting that fitness (assessed as peak VO2) can help predict cardiovascular disease 
risk in children,21 the PEN-WG views the development of robust reference values for 
CPET as a potential powerful tool in the clinicians ability to 1) identify children in whom 
the “exercise prescription” might be most beneficial, and 2) assess the success of 
exercise interventions across the child health spectrum. 
 
 
 
Page 11 of 41 Clinical and Translational Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
II.3. Training in Exercise Medicine and Science for the Next Generation of Child 
Health Researchers and Clinicians 
Improving formalized training for clinicians across disciplines represents an 
essential step toward closing the translational gap in child health exercise medicine and 
research. In an effort to understand current educational expectations related to exercise 
in pediatrics, we reviewed certification examination content outlines in general 
pediatrics, as well as in the subspecialties of pediatric cardiology, pediatric 
pulmonology, and sports medicine through respective websites.  The American Board of 
Pediatrics subspecialty content outlines and the American Board of Family Practice 
Sports Medicine Examination content outlines each include between 20 and 40 teaching 
points related to understanding the interactions of exercise with health and disease in 
children. In pediatric cardiology, pediatric pulmonology, and sports medicine there are 
competency requirements related to the administration and interpretation of clinical 
exercise tests. Interestingly, no single exercise-related teaching point is present in the 
content outlines of all of these specialties, indicating that there is little or no training in 
pediatric exercise medicine that is common to these disciplines.    
The PEN-WG (led by co-author Tod Olin) developed a brief survey to assess 1) 
current didactic opportunities related to exercise medicine in general pediatrics and 
pediatric sub-specialties, 2) current interest in a standardized curriculum among 
program directors and clinical trainees, and 3) perceived barriers to curriculum 
implementation among a potential group of users. We electronically distributed 
(www.surveyshare.com) surveys to directors of all accredited training programs in 
general pediatrics (n = 198), pediatric cardiology (n = 54), pediatric pulmonology (n = 
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49), pediatric sports medicine (n = 13), and primary care sports medicine (n = 111) in 
the United States. Surveys were initially distributed in April 2012. The study was 
approved by the National Jewish Health Institutional Review Board.  
One hundred forty-nine program directors (35%) and 178 trainees (24%) 
completed the survey. A majority (86%) of both program directors and trainees 
expressed an interest in the publication of a formal pediatric exercise curriculum. About 
two-thirds of trainees, regardless of subspecialty, expressed interest in pediatric 
exercise medicine as a dedicated track within current subspecialty training programs, 
while approximately one-fifth of trainees expressed interest in pediatric exercise 
medicine as a stand-alone fellowship. As identified by responding training program 
directors, a small percentage (14%) of training programs currently possesses a written 
pediatric exercise medicine curriculum.  Only about one-third of trainees expressed 
comfort in their training as it pertains to the evaluation of disorders related to exercise in 
pediatrics.  
This survey demonstrated that: 1) pediatric sub-specialty trainees do not feel 
adequately trained to evaluate disorders or make recommendations related to exercise; 
2) there are currently very few clinical general pediatric or pediatric subspecialty training 
programs in the United States that possess a structured curriculum to teach trainees 
about pediatric exercise medicine; and 3) a large majority of program directors and 
trainees have an interest in a structured curriculum. More than half of responding 
trainees expressed interest in dedicated pediatric exercise medicine training as a track 
within existing fellowships. Despite the current length of medical training and the 
financial debt that accompanies training, roughly one-fifth of fellows expressed interest 
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in a dedicated fellowship in pediatric exercise medicine, were such a program to be 
developed with proper accreditation. 
 
II.4. Exercise Testing Protocols, Calibration, and Equipment 
 The PEN-WG identified a myriad of potential challenges and barriers in the realm 
of testing protocols, equipment, and calibration. They are briefly reviewed and 
referenced in Table 5. Traditional exercise testing in the pediatric population utilizes 
specialized technology and equipment that measure physiologic changes occurring 
during an acute bout of progressive exercise.  The goal is to ultimately reach and 
measure a state of maximal physiologic exertion for the determination of maximal 
aerobic capacity reflected by VO2max.  VO2max requires the individual to exert an effort 
beyond typical daily exertion, and a major tenet of clinicians, scientists, and researchers 
has been that achieving this physiologic limit uncovers a broad range of physiological 
responses not otherwise detectable.  
Differences in testing protocols, testing conditions, equipment, and calibration 
may fundamentally affect the accuracy of deriving VO2max, the most important CPET 
parameter. Maximal or peak effort during progressive exercise testing is still poorly 
defined, with only scant physiologic criteria and consensus reported in the exercise 
literature.  It is known that several physiologic, environmental, anatomic, metabolic, 
anthropometric, and behavioral factors affect an individual’s ability to achieve VO2max. 
Despite its proven clinical and research utility, V•O2max, defined as a leveling off in VO2 
despite an increase in work rate, occurs only in a minority of exercise tests even in 
otherwise healthy children22-24 and maybe less so in children with chronic disease or 
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disability. Consequently, the term VO2peak is used to reflect the highest VO2 attained. 
Other criteria for a maximal effort are used, such as attainment of age-predicted 
maximal heart rate.  However, traditional criteria may not be appropriate for children 
with chronic disease. For example, in a large study of children and adolescents (mean 
age 12.3 years old) who had undergone the Fontan correction for congenital heart 
disease during childhood, only 166 of 411 patients (40%) achieved an acceptable V•
O2max using current criteria.
25 Thus, the PEN-WG believes that additional studies are 
needed to identify ways to optimize the interpretation of data collected at  peak (or 
maximal) exercise and to further explore the utility of data obtained during the  
submaximal portion (Figure 4) of typical CPET.26 
 
II.4. Recognition of Exercise as a Biomarker of Health and Disease, as Therapy, 
and as a Tool for Drug and Device Discovery and Development 
 In his advocacy of “disruptive innovation” in the creation of the new National 
Center for Advancing Translational Science (NCATS), NIH Director Francis Collins 
noted,27 “Through partnerships that capitalize on our respective strengths, NIH, 
academia, philanthropy, patient advocates, and the private sector can take full 
advantage of the promise of translational science to deliver solutions to the millions of 
people who await new and better ways to detect, treat, and prevent disease.” It was in 
this context that the PEN-WG viewed our task of addressing the gap in child health 
research exercise medicine. Following the paradigm set by Director Collins, we outline 
in Table 6 novel ways in which exercise testing could be used to achieve the objectives 
of NCATS. 
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 Further, PEN-WG recognized the need for continued innovation and research 
into physical fitness, habitual physical activity, and exercise participation assessment 
tools that can expand exercise testing to a wider group of clinicians, health care 
professionals, and researchers. CPET is invaluable, but it is expensive and time 
consuming, and requires sophisticated equipment, highly trained professionals and 
extensive data analysis. Consequently, CPET is not generally amenable for use in the 
office, school, playground, and field. Ongoing advances in ubiquitous computing,28 
activity monitoring,29;30 and videotechnologies31 must be harnessed to improve our 
ability to easily measure a “physical activity health quotient” for every child and embed 
such metrics in the next generation of clinical trials focused on child health. 
  
Page 16 of 41Clinical and Translational Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
III. RECOMMENDATIONS 
 Based on the analysis presented above, we believe that the following actions will 
begin to address the gap. 
1. Facilitate an Exercise Medicine Domain Analysis Model in partnership with 
organizations such as the HL7 Clinical Interoperability Council. Creating a 
framework for data harmonization in child health exercise science is a sina qua non 
to support the hoped-for expansion of clinical trials using CPET. 
2. Create a network of child health focused clinical and research exercise laboratories 
with the ultimate goal of establishing a data consortium. The network will: 
a. Work to establish robust reference values in child health CPET 
b. Begin to more precisely define the impact of disease and therapy on exercise 
responses during growth and development in children. 
c. Engage and collaborate with existing child health and adult exercise focused 
groups and organizations to support lif span research, global health 
initiatives, and create economies of scale in the data harmonization efforts. 
3. Promote formal programs to train child health care professionals in essential areas 
of exercise physiology, physical activity assessment, and relevant concepts of 
fitness in children. 
4. Utilize the network to establish common protocols for CPET to ensure, in particular, 
that data obtained from multicenter trials are truly comparable. 
5. Empower the Network to become a resource for review, data sharing, and 
innovation across the broad spectrum of physical activity research and clinical 
application in child health. 
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We contend that these five recommendations can only be accomplished with a 
concerted effort and strong financial as well as organizational support. The PEN-WG 
firmly believes that there is no better time than now to begin this effort. For example, the 
Affordable Care Act places great emphasis on preventive health measures in both 
adults and children. A provocative “call to action” for the larger community of exercise 
medicine clinicians and scientists to embrace translational investigation was recently 
published by a group affiliated with the American College of Sports Medicine.32 
Moreover, in the recent Institute of Medicine report on the Clinical Translational Science 
Award program,33 the reviewers noted, “For too long, research examining the safety and 
efficacy of medications and other health interventions has focused on adults, and little 
has been known about health- and development-related impacts of medications, 
devices, and preventive measures on children. Thus, clinical and translational research 
is urgently needed in the area of child health.” It is time for child health clinicians and 
researchers who are aware of the therapeutic, diagnostic, and fundamental research 
opportunities and benefits of exercise medicine to work collaboratively to garner the 
needed support to forge new ground in advancing the field of pediatric exercise 
medicine and science, and ultimately the health of our nation. 
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Figure 1. The clinical translational gap in child health exercise research. The data shown here were obtained 
from PubMed. As shown in the top panel, child health publications focused on biological mechanisms and 
pathophysiology have increased robustly for both sleep and exercise in the past 15 years. In contrast, as 
shown in the bottom panel, clinical trials using exercise testing in children have remained stagnant while 
sleep-related clinical trials have kept pace with disease-mechanism research.  
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Figure 2. Cardiopulmonary Exercise Testing (CPET) in an 11-year-old boy. CPET remains the predominant 
testing approach to determine gas exchange during exercise in children and adults. Tests are typically 
performed in laboratory using a cycle ergometer (shown here) or treadmill. CPET provides invaluable clinical 
insight both during the exercise protocol (submaximal) and at the limit of the child’s tolerance (VO2\max or 
peak VO2). CPET requires sophisticated equipment, precise calibration, skilled technicians, and robust data 
analysis and storage capabilities, and, consequently, is not readily accessible for field or most primary care 
assessments of exercise responses in children.  
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Figure 3. Variability in reference values for VO2peak.  We used predictive equations based on weight and 
calculated the expected VO2peak for a 30 kg boy or girl. Data taken from representative selected published 
studies [1–Cooper et al. (1984)34; 2–Cooper et al. (2013)26; 3–Dencker et al. (2010)35; 4–Cooper et al. 
(1984)34; 5–Cooper et al. (2013)26; 6–Dencker et al. (2010)35; 7–Rowland et al. (2000)36; 8 and 9–
Andreacci et al. (2004)37]. We found substantial differences among the predicted values. Whether this 
variability arises from real sample population differences and/or from confounding technical or 
methodological causes is not known.  
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Figure 4. Additional uses of breath-by-breath data in evaluation of cardiorespiratory and metabolic disease 
in children. This is a schematic generalization of the determination of slopes of key CPET variables from a 
ramp-type, cycle ergometry, progressive exercise protocol. Unlike the peak VO2 or VO2max, which rely on a 
relatively small set of data obtained during very heavy exercise, the slopes are derived from a much larger 
set of data obtained throughout the exercise protocol. (See Cooper et al.26)  
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Table 1: Causes and factors contributing to the clinical translational gap in child health 
exercise research. 
Key Factor Impact on the Translational Gap 
Semantic, 
syntactic, and data 
interoperability and 
harmonization 
Words matter—As the electronic medical record becomes 
universally adopted the need for formal concept mapping of 
commonly used variables such as “VO2max” or “peak VO2” will be 
essential for clinical applications and research. Data or reports 
from current CPET devices and laboratories remain inconsistent 
in how variables are reported and scaled. Lack of standardization 
in data element details can lead to costly errors and 
misinterpretations in multicenter trials or the inability to use the 
data altogether. 
The need for norms There is substantial challenge in establishing normative CPET 
data in children for a number of reasons, including: 1) accounting 
for dynamic changes occurring during growth and development; 
2) gender dimorphism; 3) ethnic, racial, socioeconomic, and 
geographic effects; and 4) finding useful normative data for 
children with chronic diseases and disabilities. 
Training in exercise 
medicine and 
science for the next 
generation of child 
Despite widespread interest in the topic of exercise and physical 
activity among child health clinical trainees, few formal didactic 
programs exist that can provide clinicians with evidence-based 
formative knowledge in exercise medicine. 
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health researchers 
and clinicians 
Exercise testing 
protocols, 
calibration, 
equipment. 
There are not as yet existing approaches to ensure that the 
results of an exercise test performed, for example, on a child at 
Boston Children’s Hospital are truly comparable to results 
obtained at UC Irvine. Such approaches are necessary if clinical 
trials using exercise are to increase. 
Recognition of 
exercise as a 
biomarker of health 
and disease, as 
therapy, and as a 
tool for drug and 
device discovery 
and development. 
Beyond the vague notion that exercise benefits child health, basic 
science concepts of exercise physiology, assessment of physical 
activity, and exercise as therapy have yet to be fully incorporated 
into practice guidelines. This lack of clinical application exists 
despite the wealth of published data demonstrating the utility of 
CPET in assessing treatment effects across the child health 
spectrum. Moreover, the idea that exercise and/or exercise 
testing can be used to promote drug and device discovery and 
development in child health is only beginning to be incorporated 
into research design. 
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Table 2. The Need for Definitions, Harmonization, and Interoperability in Child Health 
Exercise Medicine and Research. This table demonstrates through a few examples the 
diverse and sometimes conflicting understandings in the literature of CPET-related 
phrases and concepts that are all seemingly derived from the same paradigm, namely, 
maximal or peak efforts.  
 
Phrase/Concept From the Published 
Literature 
Need for Data Harmonization, and 
Syntactic and Semantic Operability 
VO2max, oxygen uptake, plateau. “The 
highest oxygen uptake obtainable for a given 
form of ergometry despite further work rate 
increases and effort by the subject. This is 
characterized by a plateau of oxygen uptake 
despite further increases in work rate.”38  
This is the classic definition for 
VO2max but assumes that a plateau in 
VO2 is obtained which occurs only 
infrequently in children 
VO2peak, peak work rate peak (Wpeak) in 
children with cystic fibrosis (CF).“The most 
important parameter of aerobic exercise 
capacity is peak oxygen uptake (VO2peak) 
commonly defined as the highest oxygen 
uptake attained during a single progressive 
cardiopulmonary exercise test (CPET) […] in 
order to optimise the use of clinical exercise 
testing, the objectives of this study was to 
The medical community has yet to 
agree that VO2peak is the most 
important parameter of CPET in 
children. The authors quoted do 
rightfully recognize that the ability to 
measure gas exchange may prove 
challenging and expensive in clinical 
pediatrics. 
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predict VO2peak [in children with CF] without 
gas analyses from Wpeak on a cycle 
ergometer.”39 
VO2peak in people with spinal cord injury 
or abnormality. 
“There are no prediction equations available 
that can be used to estimate values for 
maximum oxygen uptake (VO2max) […] in 
adolescents with disabilities using upper 
extremity exercise. Therefore, peak oxygen 
uptake (VO2peak) […] was determined for 
each subject by arm crank ergometry (ACE) 
using a standard ramp protocol on a 
magnetically braked arm ergometer.”40 
The type of exercise testing performed 
will vary widely when attempting to 
gauge exercise responses in children 
with disease or disability. In such 
cases, phrases such as VO2peak must 
be precisely defined with regard to the 
protocol. 
VO2max for hockey players. “The purpose of 
this study was to investigate a protocol for the 
determination of VO2max utilizing a motor-
driven skate treadmill (ST). The ST protocol 
replicates a hockey stride, which may provide 
more applicable information for the 
development of training programs.”41 
The optimal measurement of exercise 
responses will also be determined by 
the type of activity the child may be 
habitually engaged in. For example, 
assessing peak VO2 from cycle 
ergometry may not be useful in the 
context of measuring fitness for hockey 
players. 
Aerobic Exercise Capacity. “In the present The phrase “aerobic exercise capacity” 
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study, we compared the aerobic exercise 
capacity (peak VO2, anaerobic threshold, 
peak pulmonary ventilation (VE), peak heart 
rate (HR), and time to exhaustion) between 
normal adolescents and those with T1DM.”42 
 
is used frequently but no standard 
definition exists. In this article, it is 
loosely formulated as an unspecified 
distribution among several variables 
derived from CPET 
Regional or national specificity. “The 
Canadian Aerobic Fitness Test (CAFT) (a 
submaximal step test) was used to estimate 
aerobic fitness. Because of underestimation of 
predicted maximal aerobic power for fit and 
older adults, a modified Canadian Aerobic 
Fitness Test (mCAFT) was subsequently 
developed and employed to measure aerobic 
fitness. Both the CAFT and the mCAFT have 
been validated for 15- to 69-year-olds but not 
for younger children.”43  
Without some broader international 
data harmonization, it will be difficult to 
achieve the transformative goals 
embodied in child focused global 
health research.44;45 
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Table 3: Developing an Exercise Medicine Domain Analysis Model (DAM) with HL7 
Clinical Interoperability Council (CIC) 
Phase 0: Engage 
CIC       
Project description and scope statement accepted and approved 
by CIC 
Phase I: Data 
element, story board 
and activity diagram 
development 
Develop detailed data element definitions that include the 
context of creation and use of these data elements in the clinical 
or research environments as represented by activity diagrams 
and story boards.  A story board is narrative text that explains 
the work flow, inputs and outputs of exercise testing. Story 
boards establish a common understanding of the data elements 
in the environment and workflow in unambiguous, non-technical, 
easily understood language.  Activity diagrams are detailed 
analyses of the flow of work and data in the testing or clinical 
environment.   
Phase II: Vetting the 
work with 
professional 
societies 
Phase I work products brought to key stake holders’ meetings for 
review and approval.  The purpose of this step is to establish 
broad-based consensus of the foundational DAM elements 
before proceeding.  The output of this phase will be an approved 
data element list definitions, activity diagrams, and story boards.  
Phase III: 
Developing HL7 
standards 
Develop detailed class models and structured documents to 
support automatic data exchange and aggregation.  The results 
of this phase would include a fully-specified DAM and clinical 
document architecture (CDA) specifications consistent with HL7 
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processes.  The work products will become an ANSI-standard 
and provide systems designers and application developers 
enough detailed information to be able to develop databases, 
transactions and applications that are uniform and support 
interoperability.  
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Table 4: Barriers Related to Data and Semantic Harmonization–Results of the Data 
Architecture Survey 
Barrier Impact on Translational, Multi-Center Research 
Variable name and 
interpretation 
Different investigators or institutions use different names for the 
same variable. For instance the “AT” (anaerobic threshold) is 
semantically identical to “VT” (ventilatory threshold) or “VAT” 
(ventilatory anaerobic threshold).  
Unit ambiguity or 
preference 
Units are different for the same variable (e.g., VO2 expressed 
as either mL/min or L/min). There is lack of clarity around 1) 
relative units such as “metabolic equivalents” (METS) and 2) 
unitless variables such as respiratory exchange ratio (RER).  
Lack of consistency 
in the selection of 
outcome variables in 
CPET reports 
There is little consistency regarding which outcome variables 
should be included in CPET reports. Comments included: 
“Baseline VO2 and VCO2 data not needed, only an indication 
that the system was calibrated”; “Eliminate the METs, KCal, 
FEO2 and FECO2 columns as they are not needed in a summary 
report”; and “I would have liked to see VE as well as ventilatory 
equivalents for O2 and CO2 (VE/VO2 and VE/VCO2) and maybe 
O2-pulse on a breath-by-breath basis.” 
Missing exercise and 
environmental 
Essential environmental information such as temperature, 
barometric pressure, humidity, etc., is frequently missing. 
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information Commonly absent as well is specification of CPET system, i.e. 
breath-by-breath or mixing chamber; the specific mode of 
exercise i.e., treadmill or cycle etc.; and the type of testing 
protocol, (e.g., progressive ramp, progressive incremental, 
Wingate Anaerobic test). 
Lack of numerical 
standardization 
For example, heart rate is reported as 70.4 or 70. There is no 
unanimity on whether exercise data over time should be 
provided as “raw” breath-by-breath, smoothed breath-by-breath, 
or time-averaged.   
Data quality Many instances where individual data points are reported but 
are clearly nonphysiological (e.g., HR of 0, resting VO2 data of 
12.4 ml/kg/min). Patterns of data are suspect as well (e.g., HR 
does not increase despite increases in cycle ergometer work 
rate or treadmill rate and incline).  
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Table 5. Technical and methodological issues  in pediatric exercise testing that require 
harmonization 
 
Technical/Methodological 
Concern 
Challenges 
Testing modality  Treadmill vs. cycle ergometer 
Testing protocol Ramp, incremental, submaximal, Bruce, Wingate, etc.  
Rate of work rate increase. 
Pre- and post-exercise 
protocols and 
measurements 
Warm-up, 0-watt pedaling 
Testing equipment   Metabolic carts with different apparati for measurement 
and analysis of expired gases 
Data acquisition and 
processing  
Breath-by-breath, mixing chamber, n second averaging, 
moving averaging 
Determination of VO2peak  Criteria for max effort: HR, RER 
Expression of VO2peak 
units  
ml/min, ml/kg/min, ml/kgLBM/min, ml/kgFFM/min, % 
predicted, ml/htb (where b is an allometric power function 
such as 2/3 or ¾) 
Criteria for maximal effort   Perceived exertion, subjective assessment 
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Calibration procedures  Metabolic cart, treadmill, ergometer, calibration of work 
rate 
 
Page 38 of 41Clinical and Translational Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Table 6. New ways to configure the role of exercise medicine research in reengineering 
child health translational science 
Therapeutic 
target 
validation 
Exercise profoundly perturbs homeostasis. Consequently, interactions 
between drug effects and key metabolic homeostatic pathways can be 
readily examined in controlled animal models of exercise. 
Chemistry From the emerging notion of muscle as a hormonally active tissue to the 
alterations of blood flow and redistribution of small and large molecules 
that accompany exercise, exercise is a model for testing emerging 
research from nanoparticle drug delivery to the reinvigoration of natural 
products chemistry. 
Virtual drug 
design 
As evidenced recently by Srinivasan46 computational models of exercise 
related key physiological processes (e.g., bone formation) lend 
themselves to testing in vivo and to identification, and testing, of 
potential therapies that interact synergistically with physical activity. 
Preclinical 
toxicology 
Safety is typically tested in the relatively physically inactive state. It is 
clear that this approach has failed to identify activity dependent adverse 
effects such as the potentially serious combination of β-receptor 
agonism or antagonism and exercise in patients with coronary artery 
disease or asthma. 
Biomarkers Fitness itself may prove to be a marker of efficacy in certain drugs. 
Moreover, new research into breath biomarker, metabolic, and 
immunologic responses to acute bouts of exercise suggest that a new 
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family of activity related biomarkers of disease may be within our grasp. 
Efficacy testing As noted, since exercise provides a safe and controllable model of 
rather profound perturbation of cellular homeostasis, exercise testing at 
early phases of efficacy testing may hasten the process of identifying 
issues in efficacy and safety that have traditionally been discovered only 
after widespread use. 
Phase 0 
clinical Trials 
The advances in metabolomics and other minimally invasive 
methodologies to assess cellular homeostasis can be combined with 
exercise testing. Consequently, exercise testing might become a tool in 
phase zero clinical trials of in vivo, human testing, of potentially 
therapeutic drugs given at very low doses. 
Rescuing and 
repurposing 
NIH Director Francis Collins has suggested a bold plan whereby NCATS 
serves as an “honest broker” for matchmaking between compounds that 
have been abandoned by industry before approval and new applications 
for which these compounds might show efficacy. Exercise testing could 
prove to be a screening tool for identifying metabolic, endocrinologic, 
and immunologic diseases in which particular drugs might be 
repurposed. 
Clinical trial 
design 
Physical activity is rarely considered in clinical trial design, but a 
patient’s ability to resume as normal activity of daily living is often a 
critical endpoint of a clinical trial. Better ways to assess habitual physical 
activity and fitness through data harmonization, common protocols, and 
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concept consensus could become embedded in clinical trials and 
improve our ability to ultimately determine the efficacy of a new therapy. 
Postmarketing 
research 
The evaluation of therapeutics, diagnostics, and devices does not end at 
the time of FDA approval. Ubiquitous computing technologies such as 
the ability to assess physical activity, heart rate, and/or blood pressure 
in the field, may prove very useful in the ongoing assessment of new 
drugs as they are introduced for widespread use. 
 
Page 41 of 41 Clinical and Translational Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
